| Released | Contributor | Author | Title | Pages | Price |
|---|
| Oct 1, 2013 | New Constructs, LLC | N/A | PFE: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | Oct 1, 2013 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | | Oct 1, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Large CAP Pharma | 17 | $49 | | Oct 1, 2013 | Stock Traders Daily | Thomas H Kee Jr. | NO FOMC Tapering this year | 2 | $23 | | Sep 30, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - PFIZER INC. (PFE-N) | 12 | $25 | | Sep 30, 2013 | Stock Traders Daily | Thomas H Kee Jr. | The Investment Rate - a measure of investment demand. | 43 | $494.50 | | Sep 29, 2013 | Datamonitor | Datamonitor PLC | Pfizer Inc. | 75 | $175 | | Sep 29, 2013 | Plunkett Research, Ltd. | Jack W Plunkett | Pfizer Inc (PFE) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages | 46 | $99 | | Sep 29, 2013 | Pechala's Reports | Lubomir Pechala | PFIZER INC (PFE) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | Sep 27, 2013 | S&P Capital IQ – STARS Reports | N/A | Pfizer, Inc | 11 | $126.50 |
|
View All Reports for PFE ... |
|
|
0.41%